First-line chemotherapy for ovarian cancer – the controversy continues
نویسندگان
چکیده
منابع مشابه
First-Line Chemotherapy for Advanced Breast Cancer.
First-line chemotherapy for metastatic breast cancer has been the focus of ongoing controversy, a condition that partially reflects the imperfections of available therapy. It also partially reflects not only the imperfections in our ability to monitor response, but also the disagreements among clinicians over the goals of therapy. Each physician maintains a hierarchy of goals for the treatment ...
متن کاملFirst-line chemotherapy for the treatment of women with epithelial ovarian cancer
This guideline includes statements and recommendations based on available, high-level evidence about the use of first-line chemotherapy for the treatment of women with epithelial ovarian cancer. The guideline provides health professionals with information designed to assist in making management recommendations for improved patient outcomes. Cancer Australia also develops information specificall...
متن کاملThe pill. The controversy continues.
Oral contraceptives (OC) are, or perhaps more correctly, were, until recently, being taken by approximately 6.5 million women worldwide, which corresponds to approximately 6% of all women of reproductive age. OCs have been available since the early 1960s and there is substantial evidence to suggest that no single medication has had such a profound impact on our reproduction and social life as t...
متن کاملBeta-carotene: the controversy continues.
The three beta-carotene intervention trials: the Beta Carotene and Retinol Efficacy Trial (CARET), Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC), and Physician's Health Study (PHS) have all pointed to a lack of effect of synthetic beta-carotene in decreasing cardiovascular disease or cancer risk in well-nourished populations. The potential contribution of beta-carotene suppleme...
متن کاملThe use of antioxidants with first-line chemotherapy in two cases of ovarian cancer.
OBJECTIVE Because of poor overall survival in advanced ovarian malignancies, patients often turn to alternative therapies despite controversy surrounding their use. Currently, the majority of cancer patients combine some form of complementary and alternative medicine with conventional therapies. Of these therapies, antioxidants, added to chemotherapy, are a frequent choice. METHODS For this p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Cancer
سال: 2002
ISSN: 0007-0920,1532-1827
DOI: 10.1038/sj.bjc.6600568